Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

Eden vs Hims & Hers

Two GLP-1 providers, one scoreboard. We put Eden and Hims & Hers head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 2 · Grade A−

Eden

Visit Eden Full brief →

FDA warning letter, June 2026 — issued to Eden Health International Inc. dba Eden. See the FDA's warning letter database.

vs
No. 27 · Grade B

Hims & Hers

Visit Hims & Hers Full brief →

FDA warning letter, September 2025 — issued to Hims & Hers Health, Inc. dba Hims. See the FDA's warning letter database.

The verdict

Eden takes this head-to-head.

Eden scores 91 to 85 on our six-factor Brief Score — Eden now advertises compounded semaglutide and tirzepatide at recurring monthly prices without a separate membership fee; its FDA warning history remains relevant.

That doesn't make Hims & Hers a bad call — it's best for readers who want app-based access to branded medication and understand the separate recurring care fee. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
89
83
Supply Reliability
92
86
Transparency
93
83
Access Breadth
90
88
Clinical Oversight
92
86
Track Record
89
86
EdenBrief Score 91 · 85Hims & Hers

Price, coverage & the tracker

EdenHims & Hers
Brief Score91/100 (A−)85/100 (B)
Semaglutide

$99/mo

No separate membership fee advertised.

Same recurring rate; no long-term contract advertised.

Full price details

$99/month for compounded semaglutide on the current GLP-1 program; no separate membership fee or long-term contract advertised

Wegovy from $149/mo + membership

Pill from $149/mo; pen from $199/mo.

Membership: $39 first month, then $149/mo.

Full price details

Wegovy pill from $149/mo or pen from $199/mo, plus membership $39 first month then $149/mo

Tirzepatide

$129/mo

No separate membership fee advertised.

Same recurring rate; no long-term contract advertised.

Full price details

$129/month for compounded tirzepatide on the current GLP-1 program; no separate membership fee or long-term contract advertised

Zepbound from $299/mo + membership

Vial or KwikPen starting price.

Membership: $39 first month, then $149/mo.

Full price details

Zepbound vial or KwikPen from $299/mo, plus membership $39 first month then $149/mo

CoverageAll 50 statesNot available in all 50 states; confirm location and treatment eligibility
Brand-name accessYesYes
Oral / sublingualInjection onlyYes
On the trackerFallingprice fallingNewnew to the tracker, no prior reading

Eden: Current GLP-1 pages show $99/$129 each month, replacing the former separate-membership structure; confirm your selected program.

Hims & Hers: Hims now advertises branded GLP-1 options with a separate weight-loss membership. Compare the recurring membership charge as well as the medication price.

● Not sold on either?

CoreAge Rx tops the whole ranking at 94/100.

CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.